Physician profile
Randy Cooper
NPI 1154316495
$597,461.40
in general payments reported to CMS, 2019-2025
17 companies · $2,044 in 2025
The $2,044 reported for 2025 was more than what 89% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2020: $509K · 2021: $62K · 2022: $6,186 · 2023: $16K · 2024: $308 · 2025: $2,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $17K · Food and Beverage: $1,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $16,799.24 |
| Food and Beverage | $1,537.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $508,378.23 | 2020 | |
| Medtronic, INC. | $84,707.00 | 2021-2025 | Ellipsys Vascular Access System, Argyle |
| Angiodynamics, INC. | $1,483.33 | 2019-2020 | |
| Sonavex, INC. | $1,240.75 | 2021-2025 | Echosure, Echomark |
| Abbott Laboratories | $354.21 | 2019-2025 | Absolute Pro |
| Venturemed Group, INC. | $324.84 | 2025 | Flex Vessel Prep System |
| Avenu Medical INC. | $240.60 | 2020 | |
| Bard Peripheral Vascular, INC. | $195.46 | 2021-2022 | |
| Allergan, INC. | $175.59 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $155.96 | 2019 | |
| Amgen INC. | $82.11 | 2019 | |
| Ardelyx, INC. | $60.31 | 2024 | Ibsrela |
| Cormedix INC. | $21.33 | 2024 | Defencath |
| Boston Scientific Corporation | $15.35 | 2023 | |
| Covidien Lp | $14.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $11.92 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.